Acryl
Financials
Valuation Metrics
Acryl's Market Cap is ₩1078B. Ranked #1154 of 2,410 in KR market (top 48%), #608 of 1,631 on KOSDAQ (top 37%), #43 of 159 in Software & Services (top 27%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 107.85B KRW | KR#1,154/2,410 Sec#43/159 |
| Revenue | 13.31B KRW | KR#2,234/2,410 Sec#142/159 |
| Net Income | -2.81B KRW | KR—/2,410 Sec—/159 |
| Total Assets | 50.94B KRW | KR#2,196/2,410 Sec#120/159 |
| Net Assets | 43.75B KRW | KR#1,990/2,410 Sec#103/159 |
| Value | ||
| P/B | 2.47x | KR#2,080/2,410 Sec#138/159 |
| P/S | 8.10x | KR#2,258/2,410 Sec#153/159 |
| FCF Yield | -5.44% | KR—/2,410 Sec—/159 |
| Profitability | ||
| ROE | -6.42% | KR#1,840/2,410 Sec#117/159 |
| ROA | -5.51% | KR#1,951/2,410 Sec#125/159 |
| Op. Margin | -16.93% | KR#2,081/2,410 Sec#134/159 |
| Financial Health | ||
| Debt Ratio | 16.43% | KR#283/2,410 Sec#28/159 |
| FCF | -5.86B KRW | KR#1,530/2,410 Sec#116/159 |
| Cash | 41.39B KRW | KR#831/2,410 Sec#29/159 |
| Current Ratio | 7.79x | KR#149/2,410 Sec#16/159 |
| Performance | ||
| 1M Return | -27.33% | KR#2,165/2,410 Sec#144/159 |
| From 52W High | -82.56% | KR#2,334/2,410 Sec#155/159 |
| 1Y MDD | -80.30% | KR#2,284/2,410 Sec#150/159 |
| Trading | ||
| Volume | 31,722 shares | KR#831/2,410 Sec#47/159 |
| Trading Value | 419.8M KRW | KR#614/2,410 Sec#28/159 |
| Foreign Own. | 5.40% | KR#806/2,410 Sec#30/159 |
| Per Share | ||
| EPS | -350 KRW | KR—/2,410 Sec—/159 |
| BPS | 5,448 KRW | KR#1,445/2,410 Sec#63/159 |
Company Info
Acryl, established in 2011 and headquartered in Gangnam-gu, Seoul Metropolitan City, is an AI eXperience (AX) infrastructure specialist. The company supports the entire process from AI service construction to infrastructure operation, leveraging AI infrastructure technology. It develops NLP-related deep learning original technology for high-performance emotional recognition and creates software services to effectively deliver artificial intelligence. Its product lines include the integrated artificial intelligence platform 'Jonathan' and the medical-specialized artificial intelligence platform 'Nadia'.